pyrvinium has been researched along with Osteogenic Sarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Kang, T; Liang, X; Liao, D; Qin, G; Wang, W; Wang, X; Wang, Z; Wu, Y; Zeng, YX; Zhang, R; Zhong, L | 1 |
1 other study(ies) available for pyrvinium and Osteogenic Sarcoma
Article | Year |
---|---|
Targeting the CK1α/CBX4 axis for metastasis in osteosarcoma.
Topics: Animals; Biomarkers, Tumor; Casein Kinase Ialpha; Cell Line, Tumor; Cell Movement; Core Binding Factor Alpha 1 Subunit; Gene Expression; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HEK293 Cells; Humans; Ligases; Mice; Mutation; Neoplasm Metastasis; Osteosarcoma; p300-CBP Transcription Factors; Phosphorylation; Polycomb-Group Proteins; Promoter Regions, Genetic; Pyrvinium Compounds; Survival Analysis; Tumor Necrosis Factor-alpha; Ubiquitin-Protein Ligases; Ubiquitination | 2020 |